Meyka AI API is live for developers.Start building.
Advertisement
Zentek Ltd.

Zentek Ltd. Fundamental Analysis

ZTEKNASDAQ
HealthcareMedical - Instruments & Supplies
$0.52
$0.01(1.91%)
U.S. Market opens in 40h 30m
Advertisement

Zentek Ltd. Fundamental Analysis

Zentek Ltd. (ZTEK) shows moderate financial fundamentals with a PE ratio of -9.48, profit margin of -8.57%, and ROE of -61.26%. The company generates $0.0B in annual revenue with strong year-over-year growth of 28.26%.

Key Strengths

PEG Ratio-0.16

Areas of Concern

ROE-61.26%
Operating Margin-9.28%
Cash Position3.25%
Current Ratio1.00
We analyze ZTEK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -660.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-660.6/100

We analyze ZTEK's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZTEK struggles to generate sufficient returns from assets.

ROA > 10%
-46.51%

Valuation Score

Excellent

ZTEK trades at attractive valuation levels.

PE < 25
-9.48
PEG Ratio < 2
-0.16

Growth Score

Excellent

ZTEK delivers strong and consistent growth momentum.

Revenue Growth > 5%
28.26%
EPS Growth > 10%
18.75%

Financial Health Score

Moderate

ZTEK shows balanced financial health with some risks.

Debt/Equity < 1
0.16
Current Ratio > 1
1.00

Profitability Score

Weak

ZTEK struggles to sustain strong margins.

ROE > 15%
-6126.01%
Net Margin ≥ 15%
-8.57%
Positive Free Cash Flow
No

Key Financial Metrics

Is ZTEK Expensive or Cheap?

P/E Ratio

ZTEK trades at -9.48 times earnings. This suggests potential undervaluation.

-9.48

PEG Ratio

When adjusting for growth, ZTEK's PEG of -0.16 indicates potential undervaluation.

-0.16

Price to Book

The market values Zentek Ltd. at 6.21 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.21

EV/EBITDA

Enterprise value stands at -9.81 times EBITDA. This is generally considered low.

-9.81

How Well Does ZTEK Make Money?

Net Profit Margin

For every $100 in sales, Zentek Ltd. keeps $-8.57 as profit after all expenses.

-8.57%

Operating Margin

Core operations generate -9.28 in profit for every $100 in revenue, before interest and taxes.

-9.28%

ROE

Management delivers $-61.26 in profit for every $100 of shareholder equity.

-61.26%

ROA

Zentek Ltd. generates $-46.51 in profit for every $100 in assets, demonstrating efficient asset deployment.

-46.51%

Following the Money - Real Cash Generation

Operating Cash Flow

Zentek Ltd. generates limited operating cash flow of $-5.66M, signaling weaker underlying cash strength.

$-5.66M

Free Cash Flow

Zentek Ltd. generates weak or negative free cash flow of $-6.04M, restricting financial flexibility.

$-6.04M

FCF Per Share

Each share generates $-0.06 in free cash annually.

$-0.06

FCF Yield

ZTEK converts -7.77% of its market value into free cash.

-7.77%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.48

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.16

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.21

vs 25 benchmark

P/S Ratio

Price to sales ratio

81.85

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.61

vs 25 benchmark

ROA

Return on assets percentage

-0.47

vs 25 benchmark

ROCE

Return on capital employed

-0.62

vs 25 benchmark

How ZTEK Stacks Against Its Sector Peers

MetricZTEK ValueSector AveragePerformance
P/E Ratio-9.4829.20 Better (Cheaper)
ROE-61.26%729.00% Weak
Net Margin-856.93%-52856.00% (disorted) Weak
Debt/Equity0.160.49 Strong (Low Leverage)
Current Ratio1.004.43 Weak Liquidity
ROA-46.51%-20711.00% (disorted) Weak

ZTEK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Zentek Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-388.39%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-245.71%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ